New classes articles & resources on Made-in-China.com

Next-Generation Stevia Sweeteners Has Commenced

May 12, 2015

Work to convert existing Cargill Blair manufacturing facility to produce next-generation stevia sweeteners has commenced, under a partnership between Evolva and Cargill. Evolva will continue with the option to acquire a 45% stake in the ...

Tags: Evolva, Stevia Sweeteners

NSF Promotes an Interdisciplinary Approach to Address Fundamental Problems in Science

Jan 7, 2015

The Center for Nanoscale Science, a US National Science Foundation-funded Materials Research Science and Engineering Center (MRSEC) at Penn State University, has been awarded a six-year, $15m grant to continue research on materials at the ...

Tags: Nanoscale Science, materials research, Electrical

Fungal Infections by Organisms Such Candida Play an Increasingly Significant Role

Feb 26, 2014

A University of Otago, New Zealand, research breakthrough from the Sir John Walsh Research Institute is helping pave the way for novel antifungal drugs designed to overcome the world-wide problem of growing resistance to current treatments. ...

Tags: Aids, Drug Resistance, expand the array of antifungal treatments

TM Platform Will Be Used to Screen for GPCR-Directed Allosteric Modulator Antibodies

Feb 14, 2014

DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...

Tags: DTect-All(TM)

The South Korean Defense Ministry Plans to Recommend 150 Soldiers for a Training Course

Jan 16, 2014

When Israel founded the Talpiot program to give the Israel Defense Forces a technological edge, it spawned new classes of tech-savvy warriors who went on to build the nation's booming tech sector. Now South Korea hopes to mimic the Talpiot ...

Tags: Samsung South Korean military, South Korean military program

Anacor Pharmaceuticals Has Received a $13.5m Research Contract

Oct 23, 2013

US-based biopharmaceutical firm Anacor Pharmaceuticals has received a $13.5m research contract from the US Department of Defense, Defense Threat Reduction Agency (DTRA) to design and discover new classes of systemic antibiotics. Research ...

Tags: Anacor Pharma, Systemic Antibiotics

Researchers at A*STAR's GIS Have Discovered an Unique Gene That Controls The Generation

Aug 30, 2013

Researchers at A*STAR’s Genome Institute of Singapore (GIS) have discovered an unique gene that controls the generation of neurons, and play a crucial role in understanding serious diseases such as Alzheimer’s disease. Led by ...

Tags: Neurons Birth, unique gene

Demand for Flexible Displays Is Set to Undergo Massive Growth During The Next Seven Years

Jun 6, 2013

Demand for flexible displays is set to undergo massive growth during the next seven years, with a broad variety of applications—ranging from smartphones to giant screens mounted on buildings—driving a nearly 250 times expansion ...

Tags: Flexible Display, Smartphones, Screens

GlaxoSmithKline Has Acquired a Switzerland-Based Vaccines Company, Okairos

May 30, 2013

GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...

Tags: Glaxosmithkline, Vaccines Business

Researchers Try to Find Ways to Use an Electric Behavior to Influence Magnetic Behavior

Mar 11, 2013

Although scientists have been aware that magnetism and electricity are two sides of the same proverbial coin for almost 150 years, researchers are still trying to find new ways to use a material's electric behavior to influence its magnetic ...

Tags: New classes, magnetoelectric materials, computing technology

Therapeutics Appointed Mark Iwicki as Its President, Chief Executive Officer

Dec 27, 2012

US-based Blend Therapeutics has appointed Mark Iwicki as its president, chief executive officer and a member of the board of directors. Iwicki comes with more than 23 years of experience in the pharmaceutical industry with experience in ...

Tags: Blend Therapeutics, CEO, Iwicki, drug development

Enolsoft Co Launched Their Back to School Specials

Dec 26, 2012

HANGZHOU, CHINA, August 29, 2012 /24-7PressRelease/ -- Enolsoft Co., Ltd., a professional multimedia software developer, today launched their back to school specials ¨C 50% off for Enolsoft PDF to Word for Mac. The Enolsoft ¡ Back ...

Tags: Enolsoft, Mac Application, multimedia software, software

Immunomedics Has Developed Two New Classes of Bispecific Antibodies

Dec 19, 2012

Immunomedics has developed two new classes of bispecific antibodies, DOCK-AND-LOCK (DNL) complexes using its patented platform technology that enables site-specific conjugation of two self-assembling modules. The bispecific antibodies ...

Tags: bispecific antibody, Immunomedics, medical technology

Intel Developer Forum Was Upstaged by Apple's iPhone 5 Launch Event

Dec 18, 2012

This year's Intel Developer Forum was upstaged by Apple's iPhone 5 launch event, which to some show attendees felt like a reprise of last year, when IDF had to compete with Microsoft's Build conference. Apple's event dominated the second ...

Tags: Intel, PC, Mobile Devices, Forum Signals Market

Shire and Boston Children's to Develop New Therapies to Treat Rare Pediatric Disease

Nov 27, 2012

Shire and Boston Children's Hospital have formed a three-year, broad research collaboration to develop new therapies to treat rare pediatric diseases. As part of the agreement, Shire will make an initial upfront payment to Boston ...

Tags: pediatric diseases, Children's Hospital, new therapies

New classes

Related Products